A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats

被引:0
|
作者
Muguerza, B
Lecaroz, C
Picardi, A
CastillaCortazar, I
Quiroga, J
Cemborain, A
Prieto, J
Santidrian, S
机构
[1] UNIV NAVARRA,FAC MED,DEPT FISIOL HUMANA,PAMPLONA 31008,SPAIN
[2] UNIV NAVARRA,FAC MED,DEPT MED INTERNA,PAMPLONA 31008,SPAIN
来源
关键词
liver cirrhosis; CCl4; osteopenia; bone densitometry; rat;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to search for an experimental model to further investigate the osteopenia associated to liver cirrhosis (LC), this study has been focused on investigating the occurrence of bone disorders in male rats to which LC histologically confirmed was induced through the validated procedure of CCl4 inhalation. Length, anteroposterior and lateromedial diameters, densitometry, mechanical stress resistance, hydroxyproline (OHprol) and calcium and phosphate contents were measured in femurs from control (n = 10) and liver cirrhosis rats (n = 10). It has been found that femurs from liver cirrhosis rats showed a significant reduction (p < 0.01) in bone weight (0.254 +/- 0.003 vs 0.230 +/- 0.004 g/100 g b.w.), anteroposterior (4.08 +/- 0.06 vs 3.69 +/- 0.05 mm) and lateromedial (5.33 +/- 0.05 vs 5.08 +/- 0.04 mm, p < 0.05) diameters, resistance to mechanical stress (405.8 +/- 9.5 vs 332.5 +/- 9.1 N) and total densitometry (0.416 +/- 0.005 vs 0.381 +/- 0.004 g/cm(2)). However, no significant differences were observed in bone length, calcium, OHprol and phosphate (all expressed as mg/100 mg fresh bone tissue) contents. Therefore, the proteins matrix to mineral content-a ratio was not altered. These results indicate that in this model of experimental liver cirrhosis there is osteopenia characterized by bone frailty and reduced thickness, and it could offer an experimental model to study bone changes associated to liver cirrhosis.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 50 条
  • [21] HIGH-DOSES OF COLCHICINE FAVOR COLLAGEN REABSORPTION IN CCL4 CIRRHOTIC RATS
    MORELLI, A
    VEDOVELLI, A
    FRANCIOSINI, F
    PALMERINI, CA
    FINI, C
    FLORIDI, A
    GASTROENTEROLOGY, 1984, 86 (05) : 1333 - 1333
  • [22] Metformin reduces hepatic resistance and portal pressure in CCl4 and BDL cirrhotic rats
    Tripathi, Dinesh M.
    Erice, Eva
    Gracia-Sancho, Jordi
    Garcia-Caldero, Hector
    Sarin, Shiv K.
    Bosch, Jaime
    Carlos Garcia-Pagan, Juan
    HEPATOLOGY, 2013, 58 : 295A - 295A
  • [23] An experimental study of melting of CCl4 in carbon nanotubes
    Jazdzewska, M
    Hung, FR
    Gubbins, KE
    Sliwinska-Bartkowiak, M
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2005, 7 (22) : 3884 - 3887
  • [24] THERAPEUTIC EFFECT OF TRQ ON CHRONIC LIVER-INJURY MODEL IN RATS INDUCED BY CCL4
    YUASA, S
    SUDOH, A
    TOSHIDA, K
    TAKECHI, M
    UMEZU, K
    FOLIA PHARMACOLOGICA JAPONICA, 1985, 85 (04) : 249 - 257
  • [25] Expansion of MDSC in the liver in a CCl4 mouse model of cirrhosis
    Flint, Emilio
    Ercan, Caner
    Possamai, Lucia
    Triantafyllou, Evangelos
    Bernsmeier, Christine
    SWISS MEDICAL WEEKLY, 2022, 152 : 12S - 12S
  • [26] CHOLESTEROL ESTERS OF THE LIVER, OF THE PLASMA AND OF THE LIPOPROTEINS OF RATS POISONED WITH CCL4
    BOREA, PA
    BONORA, A
    SINISCALCHI, A
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1979, 11 (05): : 403 - 411
  • [27] CYCLIC-NUCLEOTIDES LEVELS IN THE LIVER OF RATS TREATED WITH CCL4
    PARADISI, L
    DIANZANI, MU
    CHEMICO-BIOLOGICAL INTERACTIONS, 1979, 26 (01) : 1 - 9
  • [28] TRANSMEMBRANE POTENTIAL CHANGES IN LIVER CELLS FOLLOWING CCL4 INTOXICATION
    WANDS, JR
    SMUCKLER, EA
    WOODBURY, WJ
    AMERICAN JOURNAL OF PATHOLOGY, 1970, 58 (03): : 499 - &
  • [29] OSTEOPENIA IN LIVER CIRRHOTIC RATS - A MECHANICAL RESISTANCE DENSITOMETRY AND BIOCHEMICAL-STUDY
    MUGUERZA, B
    LECAROZ, C
    PICARDI, A
    QUIROGA, J
    CASTILLACORTAZAR, I
    SANTIDRIAN, S
    PRIETO, J
    FASEB JOURNAL, 1995, 9 (03): : 162 - 162
  • [30] Quercetin in the experimental liver fibrosis induced by carbon tetrachloride (CCl4)
    Chirumbolo, Salvatore
    Bjorklund, Geir
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 55 : 254 - 256